Amneal Change To Inventory from 2010 to 2025

AMRX Stock  USD 8.53  0.36  4.05%   
Amneal Pharmaceuticals, Change To Inventory yearly trend continues to be fairly stable with very little volatility. Change To Inventory is likely to outpace its year average in 2025. Change To Inventory is the increase or decrease in the amount of inventory Amneal Pharmaceuticals, Class has over a certain period. View All Fundamentals
 
Change To Inventory  
First Reported
2016-12-31
Previous Quarter
-43.1 M
Current Value
-52 M
Quarterly Volatility
18.9 M
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 164.4 M, Interest Expense of 134.8 M or Selling General Administrative of 303.3 M, as well as many indicators such as Price To Sales Ratio of 0.83, Dividend Yield of 0.096 or Days Sales Outstanding of 132. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Change To Inventory Growth Pattern

Below is the plot of the Change To Inventory of Amneal Pharmaceuticals, Class over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Amneal Pharmaceuticals,'s Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Change To Inventory10 Years Trend
Slightly volatile
   Change To Inventory   
       Timeline  

Amneal Change To Inventory Regression Statistics

Arithmetic Mean(63,111,219)
Geometric Mean51,517,146
Coefficient Of Variation(65.98)
Mean Deviation37,037,648
Median(42,587,000)
Standard Deviation41,638,275
Sample Variance1733.7T
Range110.1M
R-Value(0.79)
Mean Square Error695.7T
R-Squared0.63
Significance0.0003
Slope(6,916,692)
Total Sum of Squares26006.2T

Amneal Change To Inventory History

2025-124 M
2024-130.5 M
2023-126.2 M
2022-102.4 M
2021-49 M
2020-113.8 M
2019-20.4 M

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Change To Inventory, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Inventory-130.5 M-124 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.